FDA Adverse Event Injury Summary report: N

CORMATRIX ECM FOR VASCULAR REPAIR

MDR report key: 5654843 · Received May 13, 2016

Report

Report Number
3005619880-2016-00012
Event Type
Injury
Date Received
May 13, 2016
Date of Event
February 26, 2016
Report Date
May 13, 2016
Manufacturer
CORMATRIX CARDIOVASCULAR, INC.
Product Code
DXZ
PMA / PMN Number
K140789
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE EXACT CAUSE OF THE OCCLUSION IS UNKNOWN. NO ADDITIONAL INFORMATION IS CURRENTLY AVAILABLE. NO SAMPLE WAS RETURNED FOR EVALUATION. THE INSTRUCTIONS FOR USE FOR THE CORMATRIX ECM FOR VASCULAR REPAIR LISTS RECURRENT STENOSIS AND VESSEL OCCLUSION AS POTENTIAL COMPLICATIONS.

Description of Event or Problem · 1

ON (B)(6) 2016, CORMATRIX CARDIOVASCULAR RECEIVED DETAILS OF AN EVENT INVOLVING THE USE OF CORMATRIX ECM FOR VASCULAR REPAIR. DETAILS OF THE EVENT ARE PROVIDED BELOW. IT WAS REPORTED THAT A PATIENT HAD A CAROTID ENDARTERECTOMY ANGIOPLASTY USING CORMATRIX ECM FOR VASCULAR REPAIR. LATER THE SITE OCCLUDED AND WAS TREATED USING A BALLOON STENT.

Description of Event or Problem · 1

ON APRIL 14, 2016, CORMATRIX CARDIOVASCULAR RECEIVED DETAILS OF AN EVENT INVOLVING THE USE OF CORMATRIX ECM FOR VASCULAR REPAIR. IT WAS ORIGINALLY REPORTED THAT A PATIENT HAD A CAROTID ENDARTERECTOMY ANGIOPLASTY USING CORMATRIX ECM FOR VASCULAR REPAIR. LATER THE SITE OCCLUDED AND WAS TREATED USING A BALLOON STENT. ON MAY 24, 2016, ADDITIONAL DETAILS WERE RECEIVED AS FOLLOWS: IT WAS REPORTED THAT AN (B)(6) FEMALE PATIENT HAD A RIGHT CAROTID ENDARTERECTOMY USING CORMATRIX ECM FOR VASCULAR REPAIR PATCH ON (B)(6) 2016. A BILATERAL CAROTID DUPLEX ULTRASOUND WAS PERFORMED ON (B)(6) 2016. THE RIGHT INTERNAL CAROTID ARTERY APPEARED TOTALLY OCCLUDED. THE SITE WAS LATER TREATED USING A BALLOON STENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
307422 CORMATRIX ECM FOR VASCULAR REPAIR PATCH, PLEDGET AND INTRACARDIAC DXZ CORMATRIX CARDIOVASCULAR, INC.

Patients

Seq Age Sex Outcome Treatment
1 86 YR Required Intervention